The Current Ratio as of November 2024 (TTM) for Fate Therapeutics, Inc. (FATE) is 8.29

According to Fate Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 8.29. This represents a change of -4.27% compared to the average of 8.66 of the last 4 quarters.

Fate Therapeutics, Inc. (FATE) Historical Current Ratio (quarterly & annually)

How has FATE Current Ratio performed in the past?

The mean historical Current Ratio of Fate Therapeutics, Inc. over the last ten years is 7.33. The current 8.29 Current Ratio has changed 11.20% with respect to the historical average. Over the past ten years (40 quarters), FATE's Current Ratio was at its highest in in the June 2020 quarter at 11.92. The Current Ratio was at its lowest in in the September 2016 quarter at 3.23.

Fate Therapeutics, Inc. (FATE) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Fate Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Fate Therapeutics, Inc. (FATE) Average Current Ratio

How has FATE Current Ratio performed in the past?

The current Current Ratio of Fate Therapeutics, Inc. (FATE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Fate Therapeutics, Inc. (FATE) Current Ratio vs. Peers

How is FATE’s Current Ratio compared to its peers?

Fate Therapeutics, Inc.’s Current Ratio is greater than Atara Biotherapeutics, Inc. (0.59), greater than Sana Biotechnology, Inc. (4.47), greater than Caribou Biosciences, Inc. (7.38), greater than Arcus Biosciences, Inc. (5.24), greater than Intellia Therapeutics, Inc. (6.73), greater than Editas Medicine, Inc. (3.75), less than CRISPR Therapeutics AG (21.64), less than Verve Therapeutics, Inc. (13.05), less than Theseus Pharmaceuticals, Inc. (29.93), greater than aTyr Pharma, Inc. (6.07), less than Relay Therapeutics, Inc. (18.42), less than Century Therapeutics, Inc. (10.39), greater than Blueprint Medicines Corporation (3.32), greater than Beam Therapeutics Inc. (5.69), greater than Prime Medicine, Inc. (6.50),

Build a custom stock screener for Fate Therapeutics, Inc. (FATE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Fate Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Fate Therapeutics, Inc. (FATE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Fate Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.